metronidazole has been researched along with Gastric Ulcer in 100 studies
Metronidazole: A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS.
metronidazole : A member of the class of imidazoles substituted at C-1, -2 and -5 with 2-hydroxyethyl, nitro and methyl groups respectively. It has activity against anaerobic bacteria and protozoa, and has a radiosensitising effect on hypoxic tumour cells. It may be given by mouth in tablets, or as the benzoate in an oral suspension. The hydrochloride salt can be used in intravenous infusions. Metronidazole is a prodrug and is selective for anaerobic bacteria due to their ability to intracellularly reduce the nitro group of metronidazole to give nitroso-containing intermediates. These can covalently bind to DNA, disrupting its helical structure, inducing DNA strand breaks and inhibiting bacterial nucleic acid synthesis, ultimately resulting in bacterial cell death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Levofloxacin-tinidazole-based triple therapy was highly effective and safe as a first-line regimen in Indian patients with gastroduodenal ulcer disease associated with H." | 9.17 | Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India. ( Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Saif, R; Shah, A; Shoukat, A; Sodhi, JS; Teli, F; Yattoo, GN; Zargar, SA, 2013) |
| " pylori-positive patients with active gastric ulcer were randomized to receive pantoprazole (40 mg) (P) and two of three antibiotics: clarithromycin (500 mg) (C), metronidazole (500 mg) (M) or amoxicillin (1000 mg) (A)." | 9.10 | Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. ( Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S, 2003) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 9.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| "60 patients with recurrent duodenal ulcers were treated with bismuth subnitrate, oxytetracycline and metronidazole." | 7.68 | [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole]. ( Berstad, A; Berstad, K; Hundal, O; Wilhelmsen, I, 1992) |
| "Levofloxacin-tinidazole-based triple therapy was highly effective and safe as a first-line regimen in Indian patients with gastroduodenal ulcer disease associated with H." | 5.17 | Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India. ( Gulzar, GM; Javid, G; Khan, BA; Khan, MA; Saif, R; Shah, A; Shoukat, A; Sodhi, JS; Teli, F; Yattoo, GN; Zargar, SA, 2013) |
| " pylori-positive patients with active gastric ulcer were randomized to receive pantoprazole (40 mg) (P) and two of three antibiotics: clarithromycin (500 mg) (C), metronidazole (500 mg) (M) or amoxicillin (1000 mg) (A)." | 5.10 | Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. ( Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S, 2003) |
| " pylori infection and duodenal ulcer, gastric ulcer or non-ulcer dyspepsia were randomly assigned to a 1 week course of either famotidine 80 mg b." | 5.09 | Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial. ( Brandstätter, G; Dragosics, B; Gschwantler, M; Hentschel, E; Hirschl, AM; Klimpfinger, M; Oberhuber, G; Pasching, E; Schütze, K; Weiss, W; Wimmer, M; Wurzer, H, 1999) |
| " pylori infection and gastric ulcers unrelated to the use of nonsteroidal antiinflammatory drugs, one week of antibacterial therapy without acid suppression heals the ulcers as well as omeprazole and reduces the rate of their recurrence." | 5.08 | Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. ( Cheng, AF; Chung, SC; Leung, VK; Li, AK; Li, MK; Ling, TK; Ng, EK; Sung, JJ; Yung, MY, 1995) |
| " pylori-positive gastritis with or without peptic ulcer, and compared with the classic 'Bazzoli regimen' (OCT: omeprazole, clarithromycin, tinidazole) in 60 matched patients." | 5.08 | Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori. ( Alvisi, V; Caselli, M; Gasbarrini, G; Gaudenzi, P; Luzzi, I; Ruina, M; Sartori, S; Trevisani, L; Tursi, A, 1997) |
| "Two 4-week triple-therapy treatment regimens, metronidazole+tetracycline+bismuth subcitrate and omeprazole+amoxycillin+bismuth subcitrate, were compared in a randomly allocated double-blind trial for their efficacy in eradicating Helicobacter pylori from the gastric mucosa of patients with gastritis and/or peptic ulcer disease." | 5.07 | Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease. ( Hahm, JS; Kim, HJ; Park, KN, 1994) |
| "The goals of this study were to assess the effectiveness of a new triple therapy consisting of amoxicillin and metronidazole with plaunotol in the eradication of Helicobacter pylori infection in humans, and to determine whether this treatment regimen reduces the rate of recurrence of gastric ulcer in patients infected with H." | 5.07 | Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate. ( Karita, M; Morshed, MG; Okita, K; Ouchi, K, 1994) |
| "The probability of recurrence for patients who received triple therapy plus ranitidine was significantly lower than that for patients who received ranitidine alone: for patients with duodenal ulcer, 12% (95% CI, 1% to 24%) compared with 95% (CI, 84% to 100%); for patients with gastric ulcer, 13% (CI, 4% to 31%) compared with 74% (44% to 100%)." | 5.07 | Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. ( Evans, DG; Evans, DJ; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Saeed, ZA, 1992) |
| "The prevalence of metronidazole and clarithromycin resistance of Helicobacter pylori strains under different growth conditions (microaerophilic or anaerobic preincubation) was tested in 56 patients suffering from gastritis and peptic ulcer." | 3.70 | Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. ( Kasenõmm, P; Kolk, H; Lõivukene, K; Maaroos, HI; Mikelsaar, M; Ustav, M, 2000) |
| " and omeprazole 20 mg daily for one week, followed by 20 mg omeprazole daily for further 3 weeks) in a prospective study of 36 patients with Helicobacter pylori-associated ulcers (10 gastric ulcers, 26 duodenal ulcers)." | 3.69 | [Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease]. ( Kobler, E; Reinhart, WH; Werth, B; Wüst, W, 1997) |
| "60 patients with recurrent duodenal ulcers were treated with bismuth subnitrate, oxytetracycline and metronidazole." | 3.68 | [Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole]. ( Berstad, A; Berstad, K; Hundal, O; Wilhelmsen, I, 1992) |
| "We have performed a retrospective study of 103 patients with either peptic ulcer or non-ulcer dyspepsia, infected with metronidazole-sensitive strains of Helicobacter pylori (H." | 3.68 | Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication? ( Bell, GD; Burridge, SM; Gant, PW; Harrison, G; Jones, PH; Powell, K; Trowell, JE; Weil, J, 1992) |
| "Furazolidone has been effective against Helicobacter pylori in Iran, with no resistance, but with intolerable side effects in the second week." | 2.73 | Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease. ( Agah, S; Ajvadi, Y; Ali-Asgari, A; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Nasseri-Moghaddam, S; Pourshams, A; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N, 2007) |
| "Healing of gastric ulcer is rapid and recurrence is infrequent after successful H pylori eradication." | 2.68 | Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group. ( Gormsen, MH; Kivilaakso, E; Pikkarainen, P; Seppälä, K; Sipponen, P, 1995) |
| "Cure of HP infection reduces the recurrence of peptic ulcer and of rebleeding from ulcer disease more effectively than does long-term maintenance therapy." | 2.68 | Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients. ( Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C, 1996) |
| "Metronidazole resistance has become an increasing problem that has severely limited the usefulness of the original triple therapy." | 2.67 | Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth. ( Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC, 1993) |
| "Duodenal ulcer recurrence and gastritis are reduced with successful Helicobacter pylori treatment." | 2.67 | Patient factors affecting Helicobacter pylori eradication with triple therapy. ( Cutler, AF; Schubert, TT, 1993) |
| "Clarithromycin resistance was significantly associated with geographic region (P = 0." | 2.41 | Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. ( Bhattacharyya, H; Hopkins, RJ; King, EC; Meyer, JM; Morris, D; Siepman, NY; Silliman, NP; Sugg, JE; Wang, W; Zhang, J, 2002) |
| "1 year after drug therapy the recurrence of CDU is revealed in 16." | 1.31 | [Current principles of the use of laparoscopic surgery in gastroduodenal ulcer]. ( Fedorov, AV; Sazhin, VP, 2001) |
| " Male Sprague-Dawley rats were dosed with two doses of metronidazole (50 mg/kg, 12 and 1 h pre-NSAID) or a single 100 mg/kg dose of tempo 1 h prior to NSAIDs." | 1.30 | Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers. ( Davies, NM; Jamali, F, 1997) |
| "Lansoprazole has a cytotoxic action against this organism, the MIC being 2." | 1.29 | Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication. ( Kawano, S; Murakami, M; Saita, H; Tsuji, S, 1996) |
| "Kinetics and bioavailability of metronidazole were studied in 17 patients admitted in our emergency care unit for gastrointestinal surgery." | 1.27 | Metronidazole kinetics and bioavailability in patients undergoing gastrointestinal surgery. ( Diquet, B; Ghesquiére, F; Levesque, C; Simon, P; Thiercelin, JF; Viars, P, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (6.00) | 18.7374 |
| 1990's | 57 (57.00) | 18.2507 |
| 2000's | 27 (27.00) | 29.6817 |
| 2010's | 10 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tseng, YY | 1 |
| Liou, JM | 1 |
| Hsu, TL | 1 |
| Cheng, WC | 1 |
| Wu, MS | 1 |
| Wong, CH | 1 |
| Naumov, RN | 1 |
| Panda, SS | 1 |
| Girgis, AS | 1 |
| George, RF | 1 |
| Farhat, M | 1 |
| Katritzky, AR | 1 |
| Makobongo, MO | 1 |
| Einck, L | 1 |
| Peek, RM | 1 |
| Merrell, DS | 1 |
| Sasaki, H | 1 |
| Nagahara, A | 1 |
| Hojo, M | 1 |
| Asaoka, D | 1 |
| Matsumoto, K | 1 |
| Osada, T | 1 |
| Watanabe, S | 1 |
| Lee, HJ | 1 |
| Kim, JI | 1 |
| Lee, JS | 1 |
| Jun, EJ | 1 |
| Oh, JH | 1 |
| Cheung, DY | 1 |
| Chung, WC | 1 |
| Kim, BW | 1 |
| Kim, SS | 1 |
| Tepeš, B | 1 |
| Vujasinović, M | 1 |
| Šeruga, M | 1 |
| Stefanovič, M | 1 |
| Forte, A | 1 |
| Jeverica, S | 1 |
| Campillo, A | 1 |
| Amorena, E | 1 |
| Ostiz, M | 1 |
| Kutz, M | 1 |
| LaIglesia, M | 1 |
| Seck, A | 1 |
| Mbengue, M | 1 |
| Gassama-Sow, A | 1 |
| Diouf, L | 1 |
| Ka, MM | 1 |
| Boye, CS | 1 |
| Sugano, H | 1 |
| Tokunaga, K | 1 |
| Tanaka, A | 1 |
| Takahashi, Si | 1 |
| Yakoob, J | 1 |
| Abid, S | 1 |
| Abbas, Z | 1 |
| Jafri, SN | 1 |
| Shah, A | 1 |
| Javid, G | 1 |
| Zargar, SA | 1 |
| Teli, F | 1 |
| Khan, BA | 1 |
| Yattoo, GN | 1 |
| Gulzar, GM | 1 |
| Sodhi, JS | 1 |
| Khan, MA | 1 |
| Shoukat, A | 1 |
| Saif, R | 1 |
| Picot, S | 1 |
| Sapin, G | 1 |
| Michault, A | 1 |
| Faulques, B | 1 |
| Becquart, JP | 1 |
| Simac, C | 1 |
| Amat, C | 1 |
| Ancelin-Malbreil, E | 1 |
| Kopański, Z | 1 |
| Piekoszewski, W | 1 |
| Schlegel-Zawadzka, M | 1 |
| Witkowska, B | 1 |
| Tabak, J | 1 |
| Puto, T | 1 |
| Trebacz, P | 1 |
| Szuszko, R | 1 |
| Schuster, MJ | 1 |
| Lai, KC | 1 |
| Lau, CS | 1 |
| Ip, WY | 1 |
| Wong, BC | 1 |
| Hui, WM | 1 |
| Hu, WH | 1 |
| Wong, RW | 1 |
| Lam, SK | 1 |
| Malfertheiner, P | 2 |
| Kirchner, T | 1 |
| Kist, M | 1 |
| Leodolter, A | 1 |
| Peitz, U | 2 |
| Strobel, S | 1 |
| Bohuschke, M | 1 |
| Gatz, G | 1 |
| Herszényi, L | 1 |
| Farup, PG | 1 |
| Gumurdulu, Y | 1 |
| Serin, E | 1 |
| Ozer, B | 1 |
| Kayaselcuk, F | 1 |
| Ozsahin, K | 1 |
| Cosar, AM | 1 |
| Gursoy, M | 1 |
| Gur, G | 1 |
| Yilmaz, U | 1 |
| Boyacioglu, S | 1 |
| Horvat, D | 1 |
| Vcev, A | 1 |
| Soldo, I | 1 |
| Timarac, J | 1 |
| Dmitrović, B | 1 |
| Misević, T | 1 |
| Ivezić, Z | 1 |
| Kraljik, N | 1 |
| Cheng, H | 1 |
| Hu, FL | 1 |
| Cheon, JH | 1 |
| Kim, SG | 1 |
| Kim, JM | 1 |
| Kim, N | 1 |
| Lee, DH | 1 |
| Kim, JS | 1 |
| Jung, HC | 1 |
| Song, IS | 1 |
| Ziemniak, W | 1 |
| Khatibian, M | 1 |
| Ajvadi, Y | 1 |
| Nasseri-Moghaddam, S | 1 |
| Ebrahimi-Dariani, N | 1 |
| Vahedi, H | 1 |
| Zendehdel, N | 1 |
| Sotoudehmanesh, R | 1 |
| Agah, S | 1 |
| Mikaeli, J | 1 |
| Pourshams, A | 1 |
| Ali-Asgari, A | 1 |
| Malekzadeh, R | 1 |
| Massarrat, S | 1 |
| Thiercelin, JF | 1 |
| Diquet, B | 1 |
| Levesque, C | 1 |
| Ghesquiére, F | 1 |
| Simon, P | 1 |
| Viars, P | 1 |
| Shirokova, KI | 1 |
| Filimonov, RM | 1 |
| Poliakova, LV | 1 |
| Schepp, W | 1 |
| Folwaczny, C | 1 |
| Seppälä, K | 1 |
| Pikkarainen, P | 1 |
| Sipponen, P | 1 |
| Kivilaakso, E | 1 |
| Gormsen, MH | 1 |
| Chong, SK | 1 |
| Lou, Q | 1 |
| Asnicar, MA | 1 |
| Zimmerman, SE | 1 |
| Croffie, JM | 1 |
| Lee, CH | 1 |
| Fitzgerald, JF | 1 |
| O'Connor, HJ | 1 |
| Kanduru, C | 1 |
| Bhutta, AS | 1 |
| Meehan, JM | 1 |
| Feeley, KM | 1 |
| Cunnane, K | 1 |
| Park, KN | 1 |
| Hahm, JS | 1 |
| Kim, HJ | 2 |
| Hudson, N | 1 |
| Brydon, WG | 1 |
| Eastwood, MA | 1 |
| Ferguson, A | 1 |
| Palmer, KR | 1 |
| Sung, JJ | 3 |
| Chung, SC | 2 |
| Ling, TK | 1 |
| Yung, MY | 2 |
| Leung, VK | 2 |
| Ng, EK | 1 |
| Li, MK | 1 |
| Cheng, AF | 1 |
| Li, AK | 1 |
| Adamek, RJ | 1 |
| Szymanski, C | 1 |
| Pfaffenbach, B | 1 |
| Opferkuch, W | 1 |
| Ricken, D | 1 |
| Wegener, M | 1 |
| Karita, M | 1 |
| Morshed, MG | 1 |
| Ouchi, K | 1 |
| Okita, K | 1 |
| Lerang, F | 2 |
| Moum, B | 2 |
| Ragnhildstveit, E | 1 |
| Labenz, J | 3 |
| Börsch, G | 4 |
| Thijs, JC | 2 |
| Van Zwet, AA | 1 |
| Oey, HB | 1 |
| Asaka, M | 1 |
| Kato, M | 1 |
| Kudo, M | 1 |
| Meguro, T | 1 |
| Kimura, T | 1 |
| Miyazaki, T | 1 |
| Inoue, K | 1 |
| Axon, AT | 1 |
| Graham, DY | 4 |
| Lew, GM | 3 |
| Ramirez, FC | 1 |
| Genta, RM | 3 |
| Klein, PD | 3 |
| Malaty, HM | 3 |
| Cutler, AF | 1 |
| Schubert, TT | 1 |
| Tillenburg, B | 1 |
| Köhl, H | 1 |
| Becker, T | 1 |
| Stolte, M | 2 |
| Diehl, HG | 1 |
| Davis, S | 1 |
| Blomgren, K | 1 |
| Alván, G | 1 |
| Bell, GD | 3 |
| Powell, KU | 2 |
| Santander, C | 1 |
| Grávalos, RG | 1 |
| Gómez-Cedenilla, A | 1 |
| Cantero, J | 1 |
| Pajares, JM | 1 |
| Tsimmerman, IaS | 1 |
| Kiseleva, RP | 1 |
| Freĭnd, GG | 1 |
| Yousfi, MM | 1 |
| El-Zimaity, HM | 1 |
| Cole, RA | 1 |
| Park, SM | 1 |
| Park, J | 1 |
| Chang, SK | 1 |
| Yoo, BC | 1 |
| Kawano, S | 1 |
| Murakami, M | 1 |
| Saita, H | 1 |
| Tsuji, S | 1 |
| Moshkowitz, M | 1 |
| Konikoff, FM | 1 |
| Peled, Y | 1 |
| Brill, S | 1 |
| Hallak, A | 1 |
| Tiomny, E | 1 |
| Santo, M | 1 |
| Bujanover, Y | 1 |
| Gilat, T | 1 |
| Caselli, M | 1 |
| Trevisani, L | 1 |
| Tursi, A | 1 |
| Sartori, S | 1 |
| Ruina, M | 1 |
| Luzzi, I | 1 |
| Gaudenzi, P | 1 |
| Alvisi, V | 1 |
| Gasbarrini, G | 1 |
| Haug, JB | 1 |
| Tolås, P | 1 |
| Breder, O | 1 |
| Aubert, E | 1 |
| Høie, O | 1 |
| Søberg, T | 1 |
| Flaaten, B | 1 |
| Farup, P | 1 |
| Berge, T | 1 |
| Kung, NN | 1 |
| Yuen, NW | 1 |
| Ng, PW | 1 |
| Wong, KC | 1 |
| Chung, EC | 1 |
| Lim, BH | 1 |
| Choi, CH | 1 |
| Li, TH | 1 |
| Ma, HC | 1 |
| Kwok, SP | 1 |
| Jarczyk, G | 1 |
| Jarczyk, J | 1 |
| Raczyńska, A | 1 |
| Jedrzejczyk, W | 1 |
| Davies, NM | 1 |
| Jamali, F | 1 |
| Kobler, E | 1 |
| Werth, B | 1 |
| Wüst, W | 1 |
| Reinhart, WH | 1 |
| Chan, FK | 1 |
| To, KF | 1 |
| Lee, YT | 1 |
| Chan, CS | 1 |
| Li, EK | 1 |
| Woo, J | 1 |
| Bobrzyński, A | 1 |
| Gedliczka, O | 1 |
| Bielański, W | 1 |
| Stachura, J | 1 |
| Konturek, S | 1 |
| Budzyński, A | 1 |
| Glaser, J | 1 |
| Hein, J | 1 |
| Daikeler, R | 1 |
| Weithofer, G | 1 |
| Vieth, M | 1 |
| Schmidt, M | 1 |
| Carnicer, J | 1 |
| Koizumi, W | 1 |
| Tanabe, S | 1 |
| Hibi, K | 1 |
| Imaizumi, H | 1 |
| Ohida, M | 1 |
| Okabe, H | 1 |
| Saigenji, K | 1 |
| Okayasu, I | 1 |
| de Boer, WA | 1 |
| Haeck, PW | 1 |
| Otten, MH | 1 |
| Mulder, CJ | 1 |
| Lokhvitskiĭ, SV | 1 |
| Darvin, VV | 1 |
| Proshin, AV | 1 |
| Bashirova, ES | 1 |
| Butorov, IL | 1 |
| Makino, M | 1 |
| Koga, T | 1 |
| Ito, K | 1 |
| Kawada, H | 1 |
| Tabata, K | 1 |
| Yang, L | 1 |
| Eshraghi, J | 1 |
| Fassihi, R | 1 |
| Nilsson, F | 1 |
| Walder, M | 1 |
| Van der Wouden, EJ | 1 |
| Zwet, AA | 1 |
| Kooy, A | 1 |
| Kleibeuker, JH | 1 |
| van der Hulst, RW | 2 |
| van 't Hoff, BW | 1 |
| van der Ende, A | 2 |
| Tytgat, GN | 2 |
| Gisbert, JP | 1 |
| Boixeda, D | 1 |
| Martín de Argila, C | 1 |
| García Plaza, A | 1 |
| Gschwantler, M | 1 |
| Dragosics, B | 1 |
| Schütze, K | 1 |
| Wurzer, H | 1 |
| Hirschl, AM | 1 |
| Pasching, E | 1 |
| Wimmer, M | 1 |
| Klimpfinger, M | 1 |
| Oberhuber, G | 1 |
| Brandstätter, G | 1 |
| Hentschel, E | 1 |
| Weiss, W | 1 |
| Grilli, R | 1 |
| Lõivukene, K | 1 |
| Kolk, H | 1 |
| Maaroos, HI | 1 |
| Kasenõmm, P | 1 |
| Ustav, M | 1 |
| Mikelsaar, M | 1 |
| Mansurova, FKh | 1 |
| Kadyrov, DM | 1 |
| Odinaev, RI | 1 |
| Ishankulova, DM | 1 |
| Hurenkamp, GJ | 1 |
| Grundmeijer, HG | 1 |
| Gomollón, F | 1 |
| Valdepérez, J | 1 |
| Garuz, R | 1 |
| Fuentes, J | 1 |
| Barrera, F | 1 |
| Malo, J | 1 |
| Tirado, M | 1 |
| Simón, MA | 1 |
| Nguyen, HN | 1 |
| Sazhin, VP | 1 |
| Fedorov, AV | 1 |
| Maev, IV | 1 |
| V'iuchnova, ES | 1 |
| Lebedev, EG | 1 |
| Dicheva, DT | 1 |
| Ovsiannikova, EV | 1 |
| Antonenko, OM | 1 |
| Shchekina, MI | 1 |
| Wongkusoltham, P | 1 |
| Vilaichone, RK | 1 |
| Kullavanijaya, P | 1 |
| Phaosawadi, K | 1 |
| Mahachai, V | 1 |
| Vichev, E | 1 |
| Krŭstev, N | 1 |
| Krŭstev, D | 1 |
| Baeva, N | 1 |
| Kiselova, A | 1 |
| Ianev, N | 1 |
| Meyer, JM | 1 |
| Silliman, NP | 1 |
| Wang, W | 1 |
| Siepman, NY | 1 |
| Sugg, JE | 1 |
| Morris, D | 1 |
| Zhang, J | 1 |
| Bhattacharyya, H | 1 |
| King, EC | 1 |
| Hopkins, RJ | 1 |
| Gupta, MB | 1 |
| Nath, R | 1 |
| Tangri, KK | 1 |
| Bhargava, KP | 1 |
| Wilhelmsen, I | 1 |
| Hundal, O | 1 |
| Berstad, K | 1 |
| Berstad, A | 1 |
| Burridge, SM | 2 |
| Spencer, G | 1 |
| Bolton, G | 1 |
| Purser, K | 1 |
| Brooks, S | 1 |
| Prosser, S | 1 |
| Harrison, G | 2 |
| Gant, PW | 2 |
| Evans, DG | 2 |
| Evans, DJ | 2 |
| Saeed, ZA | 1 |
| Dobrilla, G | 1 |
| Piazzi, L | 1 |
| Amplatz, S | 1 |
| Benvenuti, S | 1 |
| Di Fede, F | 1 |
| Powell, K | 1 |
| Weil, J | 1 |
| Jones, PH | 1 |
| Trowell, JE | 1 |
| Alpert, LC | 1 |
| Becx, MC | 1 |
| Janssen, AJ | 1 |
| Clasener, HA | 1 |
| de Koning, RW | 1 |
| Prebrazhenskiĭ, VN | 1 |
| Klimov, NP | 1 |
| Katkov, VI | 1 |
| Zhuravlev, AP | 1 |
| Bozh'ev, VI | 1 |
| Quintero Diaz, M | 1 |
| Sotto Escobar, A | 1 |
| Soulé, JC | 1 |
| Dutreuil, C | 1 |
| Delchier, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Efficacy of Concomitant Therapy for Eradication of Helicobacter Pylori[NCT01922765] | Phase 4 | 540 participants (Anticipated) | Interventional | 2013-08-31 | Recruiting | ||
| Rifaximin Associated With Classic Triple Therapy (Inhibitor of Proton Pump, Amoxicillin and Clarithromycin) for the Eradication of Helicobacter Pylori Infection[NCT03124199] | Phase 3 | 40 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
| Comparing the Efficacy and Impact on Gastrointestinal Microbiome of Reverse Hybrid Therapy and Bismuth Quadruple Therapy in Helicobacter Pylori Eradication[NCT02547038] | 352 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| A Prospective Randomized Trial of Levofloxacin-amoxicillin Triple Therapy vs. Levofloxacin-tetracycline Quadruple Therapy in Second-line Helicobacter Pylori Treatment[NCT02978157] | 102 participants (Actual) | Interventional | 2015-02-28 | Completed | |||
| Comparison of Hybrid and Bismuth Containing Quadruple Therapies for Helicobacter Pylori Eradication: a Randomized Controlled Trial[NCT02541864] | 330 participants (Actual) | Interventional | 2013-07-31 | Completed | |||
| Comparison of Two Rescue Therapies for Helicobacter Pylori Infection - A Multicenter Randomized Controlled Trial[NCT02547012] | 51 participants (Actual) | Interventional | 2013-11-30 | Completed | |||
| Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection - a Randomized Controlled Trial (REHYTRI Study)[NCT02359435] | 440 participants (Actual) | Interventional | 2012-10-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Percentage of patients that has comply with treatment, considered as intake of more than 90% of study drugs in patients who attended the post-treatment visit. (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 100 |
Percentage of Participants with H.Pylori Infection Eradication confirmed with urea breath test at least 4 weeks after the end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | percentage of participants (Number) |
|---|---|
| Rifaximin | 61 |
Patients with side effects present during treatment and in the 4 weeks after end of treatment (NCT03124199)
Timeframe: 1 month
| Intervention | participants (Number) | ||||
|---|---|---|---|---|---|
| with diarrhea | with metallic taste | headache | nausea | abdominal pain | |
| Rifaximin | 13 | 9 | 5 | 5 | 1 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (Number of Participants With Complete Eradication of Helicobacter Pylori) (NCT02547038)
Timeframe: sixth week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 169 |
| (Panto+Amox+Clar+Metr)+(Panto+Amox) | 170 |
Number of participants with negative H pylori status in follow-up tests as a measure of successful eradication (NCT02978157)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo | 36 |
| Esomeprazole+Bismuth+Tetra+Levo | 49 |
Repeated endoscopy with rapid urease test, histological examination and culture or urea breath tests are conducted to assess H. pylori status. (NCT02541864)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Pantoprazole+Bismuth+Tetra+Metro | 154 |
| Hybrid Therapy | 154 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02547012)
Timeframe: six weeks after the end of anti-H pylori therapy.
| Intervention | participants (Number) |
|---|---|
| Esomeprazole+Amox+Levo+Tetra | 13 |
| Esomeprazole+Amox+Levo | 21 |
Evaluate eradication outcome by endoscopy urease test and histology or urea breath test (NCT02359435)
Timeframe: at the 6th week after the end of anti- H. pylori therapy
| Intervention | participants (Number) |
|---|---|
| Reverse Hybrid Therapy | 206 |
| Standard Triple Therapy | 191 |
10 reviews available for metronidazole and Gastric Ulcer
| Article | Year |
|---|---|
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2002 |
[Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzym | 2003 |
[Guidelines for the diagnosis and treatment of H. pylori infection].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Duodenal Ulcer; Dysp | 2003 |
Helicobacter pylori infection.
Topics: Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Hu | 1993 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; | 1996 |
[Antibiotic resistance of Helicobacter pylori in Malmö. Therapeutic success in spite of antibiotic resistance].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, | 1999 |
[Treatment of Helicobacter pylori infections].
Topics: Clarithromycin; Clinical Protocols; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Fema | 1999 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double | 2001 |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarith | 2002 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
41 trials available for metronidazole and Gastric Ulcer
| Article | Year |
|---|---|
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combina | 2015 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Sch | 2016 |
Safety and efficacy of 1-week levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori-related peptic ulcer disease in Kashmir, India.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Dru | 2013 |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Cl | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Be | 2003 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Fe | 2003 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agent | 2004 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Sc | 2005 |
Combinations containing amoxicillin-clavulanate and tetracycline are inappropriate for Helicobacter pylori eradication despite high in vitro susceptibility.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacteri | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 2006 |
Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; | 2007 |
[Antibacterial treatment of gastric ulcers associated with Helicobacter pylori without acid suppression].
Topics: Aluminum Hydroxide; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; | 1995 |
Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therap | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Com | 1994 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Heli | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
Antibacterial treatment of gastric ulcers associated with Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Confidence Intervals; Female; Follow-Up Studi | 1995 |
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Benzimidazoles; Biopsy; Clarithrom | 1995 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastr | 1994 |
Efficacy and side effects of a triple drug regimen for the eradication of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, C | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infection | 1993 |
Patient factors affecting Helicobacter pylori eradication with triple therapy.
Topics: Adult; Age Factors; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer | 1993 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug The | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Du | 1996 |
Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Topics: Adult; Antacids; Anti-Ulcer Agents; Antitrichomonal Agents; Duodenal Ulcer; Female; Helicobacter Inf | 1996 |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Admin | 1996 |
Short-term low-dose triple therapy with azithromycin, metronidazole and lansoprazole appears highly effective for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Bacterial Agents; A | 1997 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromyci | 1997 |
Anti-Helicobacter pylori treatment in bleeding ulcers: randomized controlled trial comparing 2-day versus 7-day bismuth quadruple therapy.
Topics: Activities of Daily Living; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Adm | 1997 |
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bismuth; Drug Administration Schedul | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; H | 1997 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Heli | 1998 |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clar | 1998 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistan | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration S | 1999 |
Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori--a randomized, controlled trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Drug Resis | 1999 |
Equally high efficacy of 4, 7 and 10-day triple therapies to eradicate Helicobacter pylori infection in patients with ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benef | 2000 |
Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Bismuth; Circadian Rhythm; Drug Administration Schedule; Drug Resistance, Microbial; Dr | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicoba | 1992 |
Helicobacter pylori and gastric ulcer therapy: reflections and uncertainties.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Cefixime; Cefotaxime; Cimetidine; Drug Therapy, Combinatio | 1992 |
Metronidazole versus cimetidine in treatment of gastroduodenal ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Female; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer | 1986 |
50 other studies available for metronidazole and Gastric Ulcer
| Article | Year |
|---|---|
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulc | 2014 |
Synthesis and QSAR study of novel anti-inflammatory active mesalazine-metronidazole conjugates.
Topics: Animals; Anti-Inflammatory Agents; Indomethacin; Mesalamine; Metronidazole; Mice; Molecular Structur | 2015 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug | 2013 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dise | 2013 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug | 2016 |
Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Duodenal Ulcer | 2009 |
[Helicobacter pylori eradication therapy for gastric ulcer in elderly].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Adminis | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resis | 2010 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clari | 2002 |
[The efficacy of the Helicobacter pylori eradication in people of an advanced age].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections | 2002 |
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; China; Clarithromyci | 2005 |
Metronidazole kinetics and bioavailability in patients undergoing gastrointestinal surgery.
Topics: Administration, Oral; Adolescent; Adult; Aged; Biological Availability; Duodenal Ulcer; Female; Huma | 1984 |
[Metronidazole in the treatment of peptic ulcer].
Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Female; Humans; Male; Metronidazole; Middle Aged; Peptic Ul | 1981 |
[Omeprazole + clarithromycin + metronidazole--a new standard for eradication of Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Du | 1995 |
Effect of Helicobacter pylori eradication on peptic ulcer healing.
Topics: Adult; Aged; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacte | 1995 |
[Alternative treatment of Helicobacter pylori infections].
Topics: Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Sto | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Fem | 1994 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobac | 1993 |
[One week triple therapy for eradication of Helicobacter pylori infection: simple and effective].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Adm | 1995 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1996 |
Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Case-Control Studies; Drug T | 1996 |
[The validation and effect of the prophylactic (antirelapse) treatment of peptic ulcer patients with chlorozil and metronidazole].
Topics: Adult; Anti-Ulcer Agents; Choline; Drug Evaluation; Duodenal Ulcer; Female; Follow-Up Studies; Human | 1996 |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; | 1996 |
[Early results of treating Helicobacter pylori infections in patients with gastric ulcer and gastritis].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Dr | 1996 |
Pharmacological protection of NSAID-induced intestinal permeability in the rat: effect of tempo and metronidazole as potential free radical scavengers.
Topics: Administration, Oral; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomar | 1997 |
[Effectiveness of short-term triple therapy for healing Helicobacter pylori infection in ulcer disease].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin | 1997 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; An | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-U | 1998 |
[Evaluation of results of surgical treatment of peptic ulcer associated with Helicobacter pylori].
Topics: Adult; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Evaluation Studi | 1998 |
Delayed healing of chronic gastric ulcer after Helicobacter pylori infection in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Metronida | 1998 |
A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation.
Topics: Algorithms; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Del | 1999 |
Helicobacter pylori: related to rosacea?
Topics: Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Helicobacter In | 2000 |
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia.
Topics: Adolescent; Adult; Aerobiosis; Aged; Anaerobiosis; Anti-Bacterial Agents; Bacterial Proteins; Clarit | 2000 |
[Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Fa | 2000 |
[Eradication therapy of Helicobacter pylori in antibiotic resistance].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combinatio | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duode | 2001 |
Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Topics: Adult; Aged; Chi-Square Distribution; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Fe | 2001 |
[Gastroduodenitis and ulcers--statistical study for 1998].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bulgaria; Clarithromycin; Drug Ther | 2000 |
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobac | 2002 |
Antiulcerogenic action of metronidazole in rats and guinea-pigs.
Topics: Animals; Female; Guinea Pigs; Male; Metronidazole; Rats; Stomach Ulcer | 1976 |
[Treatment of stomach ulcer with bismuth subnitrate, oxytetracycline and metronidazole].
Topics: Adult; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Male | 1992 |
Does a previous course of tripotassium dicitrato bismuthate affect the subsequent chances of successful Helicobacter pylori eradication?
Topics: Adult; Aged; Drug Administration Schedule; Drug Resistance, Microbial; Duodenal Ulcer; Dyspepsia; Fe | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter | 1992 |
Factors influencing the eradication of Helicobacter pylori with triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastriti | 1992 |
Metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Campylobacter; Campylobacter Infections; Drug Resistance, Microbial; Female; Gastritis; | 1990 |
[Role of Campylobacter pylori and mucous microflora in the pathogenesis of long-non-healing stomach ulcers].
Topics: Adult; Ampicillin; Anti-Ulcer Agents; Campylobacter; Chronic Disease; Female; Gastric Mucosa; Humans | 1991 |
[Search for the best procedure for Campylobacter eradication. Results of long-term studies are still unavailable].
Topics: Anti-Ulcer Agents; Campylobacter Infections; Drug Therapy, Combination; Follow-Up Studies; Gastritis | 1989 |
[Prevention by metronidazole of gastric mucosal lesions induced by absolute alcohol in the rat].
Topics: Animals; Ethanol; Gastric Mucosa; Male; Metronidazole; Rats; Stomach Ulcer | 1985 |